Propel Bio Management »

Ocular Therapeutix shares owned by Propel Bio Management

Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Ocular Therapeutix

Tip: Access up to 7 years of quarterly data

All positions including Ocular Therapeutix held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocular Therapeutix by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.2M 382k 8.44

More positions owned by Propel Bio Management

Plains Gp Hldgs Ltd Partnr Int A (PAGP)
Achieve Life Sciences (ACHV)
Phathom Pharmaceuticals (PHAT)
Delcath Sys Com New (DCTH)
Corcept Therapeutics Incorporated (CORT)
Abeona Therapeutics Com New (ABEO)
Vor Biopharma Com New (VOR)
Kyverna Therapeutics (KYTX)
Milestone Pharmaceuticals (MIST)
Celldex Therapeutics Com New (CLDX)
Compass Pathways Sponsored Ads (CMPS)
Miragen Therapeutics (VRDN)
Inventiva Sa Ads (IVA)
Sab Biotherapeutics Com New (SABS)
Health Sciences Acq Corp 2 (OBIO)

View all positions for Propel Bio Management

Top funds holding Ocular Therapeutix

FMR
Deep Track Capital
BlackRock
Summer Road
Vanguard Group
venBio Select Advisor
VR Adviser
Vanguard Capital Management
Point72 Asset Management
Adage Capital Partners GP
Geode Capital Management
State Street Corporation
Alliancebernstein
Logos Global Management
Octagon Capital Advisors

View all funds holding Ocular Therapeutix